Aucentra 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
auceliciclib (AU3-14) / Aucentra
ACTRN12621000479808: An interventional study to safety, tolerability (how well a substance is tolerated by patients), and Pharmacokinetics (PK, the measure of how the human body processes a substance) of different dosages of Auceliciclib when given to patients with advanced solid tumours as either the only treatment, or in patients with a specific type of cancer, Glioblastoma multiforme (GBM), when given together with a standard of care treatment, Temozolomide (TMZ).

Completed
1/2
60
 
Aucentra Therapeutics Pty Ltd., Aucentra Therapeutics Pty Ltd.
Cancer, Glioblastoma multiforme (GBM), Solid tumors
 
 
sunaciclib (AU-07) / Qianhong Bio-Pharma, Aucentra
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Recruiting
2
53
RoW
QHRD107 capsule，Venclexta and Azacitidine, CDK9 inhibitors
Changzhou Qianhong Bio-pharma Co., Ltd.
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
02/25
05/25
CTR20190521: Clinical study on the safety of QHRD107 capsules

Completed
1
24
China
QHRD107 - Qianhong Bio-Pharma
Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
Acute myeloid leukemia (AML)
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
auceliciclib (AU3-14) / Aucentra
ACTRN12621000479808: An interventional study to safety, tolerability (how well a substance is tolerated by patients), and Pharmacokinetics (PK, the measure of how the human body processes a substance) of different dosages of Auceliciclib when given to patients with advanced solid tumours as either the only treatment, or in patients with a specific type of cancer, Glioblastoma multiforme (GBM), when given together with a standard of care treatment, Temozolomide (TMZ).

Completed
1/2
60
 
Aucentra Therapeutics Pty Ltd., Aucentra Therapeutics Pty Ltd.
Cancer, Glioblastoma multiforme (GBM), Solid tumors
 
 
sunaciclib (AU-07) / Qianhong Bio-Pharma, Aucentra
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Recruiting
2
53
RoW
QHRD107 capsule，Venclexta and Azacitidine, CDK9 inhibitors
Changzhou Qianhong Bio-pharma Co., Ltd.
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
02/25
05/25
CTR20190521: Clinical study on the safety of QHRD107 capsules

Completed
1
24
China
QHRD107 - Qianhong Bio-Pharma
Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
Acute myeloid leukemia (AML)
 
 

Download Options